Science ❯ Genetics

Gene Editing

CRISPR CRISPR Technology CRISPR/Cas9 Crispr Technology CRISPR-Cas9 Therapeutic Applications Animal Biology Therapeutic Proteins TALE Technology Xenotransplantation Research Prime Editing System Xenotransplantation Techniques DNA-Based Parasite Gene-Edited Meat Riboswitch Technology Genetic Engineering Colossal Biosciences DNA Replication Crispr-Cas9 Prime Editor Components Homology-Directed Repair Gene Doping Recombinase Technology Crispr Research Genetic Diversity De-extinction Animal Models Poc5 Protein RNA-based Therapies Reverse Transcription Process Recombinases Gene Therapy Base Editing

FDA Proposes ‘Plausible Mechanism’ Pathway for Individualized Rare-Disease Therapies

Sponsors would gain a route to approval based on plausible biology, with obligations to verify outcomes after launch.

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

POC5 Protein Proves Essential for Sperm Tail Assembly in Mouse Study

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Small Subset of Newborn Liver Cells Drives Growth, Recasting Pediatric Gene Therapy Timing

CRISPR-Edited Snail Establishes First Model for Full Eye Regrowth

CRISPR Allelic-Drive Switch Renders Mosquitoes Unable to Transmit Malaria

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

IFN-γ Receptor Knockout Extends CAR-T Cell Lifespan and Boosts Tumor Combat